Xu Can-xia, Zhong Hua, Shen Shou-rong
Department of Gastroenterology, Third Xiangya Hospital, Central South University, Changsha, 410013, China.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Dec;29(6):643-6.
To explore the relationship among Helicobacter pylori (H. pylori) infection, the invasion and metastasis of the gastric carcinoma, and the MMP-2 and TIMP-2 expression.
The Warthin-starry method, rapid urease test and 14C-UBT were used to detect the infection of H. pylori. The expression of MMP-2 and TIMP-2 in 22 patients with gastric carcinoma infected by H. pylori and 22 patients with gastric carcinoma but not infected were detected by immunohistochemistry method.
The incidence of serosal invasion and lymph node metastasis in patients with gastric carcinoma infected by H. pylori (81.8% and 72.7% respectively) was significantly higher than that in patients with gastriccarcinoma but not infected (50.0% and 36.4% respectively, P < 0.05). The positive rates of MMP-2 expression in the invasive group (96.6%) and in the metastasis group (100.0%) were significantly higher than that in the non-invasive group (40.0%) and the non-metastasis group (50.0%), whereas the positive rates of TIMP-2 expression in the invasive group (48.3%) and in the metastasis group (45.8%) were significantly lower than that in the non-invasive group (86.7%) and the non-metastasis group (80.0%). The ratios of MMP-2/TIMP-2 in the invasive group (6.86) and in the metastasis group (7.94) were significantly higher than that in the non-invasive group (0.87) and the non-metastasis group (1.07). The positive rate of MMP-2 expression in patients with gastric carcinoma infected by H. pylori (90.9%) was significantly higher than that in patients with gastric carcinoma but not infected (63.6%), whereas the positive rate of TIMP-2 expression in patients with gastric carcinoma infected by H. pylori (36.4%) was significantly lower than that in patients with gastric carcinoma but not infected (P < 0.01). The ratio of MMP-2/TIMP-2 in patients with gastric carcinoma infected by H. pylori (7.73) was significantly higher than that in patients with gastric carcinoma but not infected (P < 0.01).
associated with the increase of the MMP-2 expression, the decrease of the TIMP-2 expression and the increase of the ratio of MMP-2/TIMP-2 that the incidence of serosal invasion and lymph node metastasis in patients with gastric carcinoma increases by H. pylori infection.
探讨幽门螺杆菌(H. pylori)感染、胃癌侵袭转移与基质金属蛋白酶-2(MMP-2)及金属蛋白酶组织抑制因子-2(TIMP-2)表达之间的关系。
采用Warthin-starry法、快速尿素酶试验及14C-尿素呼气试验(14C-UBT)检测H. pylori感染情况。采用免疫组织化学方法检测22例H. pylori感染的胃癌患者及22例未感染的胃癌患者中MMP-2和TIMP-2的表达。
H. pylori感染的胃癌患者浆膜侵犯和淋巴结转移发生率(分别为81.8%和72.7%)显著高于未感染的胃癌患者(分别为50.0%和36.4%,P<0.05)。MMP-2表达阳性率在侵犯组(96.6%)和转移组(100.0%)显著高于未侵犯组(40.0%)和未转移组(50.0%),而TIMP-2表达阳性率在侵犯组(48.3%)和转移组(45.8%)显著低于未侵犯组(86.7%)和未转移组(80.0%)。MMP-2/TIMP-2比值在侵犯组(6.86)和转移组(7.94)显著高于未侵犯组(0.87)和未转移组(1.07)。H. pylori感染的胃癌患者MMP-2表达阳性率(90.9%)显著高于未感染的胃癌患者(63.6%),而H. pylori感染的胃癌患者TIMP-2表达阳性率(36.4%)显著低于未感染的胃癌患者(P<0.01)。H. pylori感染的胃癌患者MMP-2/TIMP-2比值(7.73)显著高于未感染的胃癌患者(P<0.01)。
H. pylori感染可使胃癌患者浆膜侵犯和淋巴结转移发生率增加,与MMP-2表达增加、TIMP-2表达降低及MMP-2/TIMP-2比值升高有关。